Coronavirus Update: Moderna Lifted By BARDA funding, Europe Looks For Exit Strategy, Vaccine Funds

Boost For Vaccine Frontrunner

Plus: Moleculin hopes to move 2-DG prodrug into clinic, India progresses niche COVID-19 defenses and more.

Dusseldorf_Street
Customers observe social distancing rules outside a local shop in Dusseldorf, Germany. Europe is looking for a controlled return to normality, but the process will be slow

Moderna Inc. has received a major cash infusion from the US Biomedical Advanced Research and Development Authority (BARDA) to support its COVID-19 vaccine program.

The commitment of up to $483m will help fund activities through licensure. The mRNA-1273 vaccine started a Phase I trial...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Archive

More from Scrip